SCHEMBL21136848

SCHEMBL21136848

Cc1cc2c(N3CCN(C(=O)OC(C)(C)C)CC3)c([N+](=O)[O-])cnc2cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.47
ALDH1A1 P00352 4/20 0.45
MAPT P10636 4/20 0.45
LMNA P02545 3/20 0.45
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
KCNH2 Q12809 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
PGK1 P00558 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
CCNK O75909 1/20 0.39
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39
CCND3 P30281 1/20 0.39
CDK9 P50750 1/20 0.39
CDK6 Q00534 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HSP90AA1 P07900 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21136775 0.88 MET (0.47) METALDH1A1MAPTLMNAMEN1
SCHEMBL21136735 0.79 KCNH2 (0.47) METALDH1A1MAPTLMNAMEN1
SCHEMBL15770114 0.79 ALDH1A1 (0.53) METALDH1A1MAPTLMNAMEN1
SCHEMBL13283941 0.77 IDE (0.58) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL17030861 0.77 MEN1 (0.46) MAPTLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL17030841 0.77 KIT (0.53) MEN1KMT2APDGFRB
SCHEMBL2922036 0.77 PDGFRB (0.59) METALDH1A1MAPTLMNAPDGFRB
SCHEMBL7481750 0.77 MAPT (0.57) METALDH1A1MAPTLMNAMEN1
SCHEMBL30502025 0.77 MAPT (0.58) METALDH1A1MAPTLMNAKCNH2
SCHEMBL14938498 0.77 MAPT (0.58) METALDH1A1MAPTLMNAKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed